Azenta Q1 Earnings Call Highlights

Azenta logo 5 medical stocks growing earnings by triple digits Azenta (NASDAQ:AZTA) reported fiscal first-quarter 2026 revenue of $149 million, up 1% on a reported basis but down 1% organically, as continued macro uncertainty and cautious capital spending weighed on parts of its portfolio. Management reaffirmed full-year guidance calling for 3% to 5% organic revenue growth and roughly 300 basis points of adjusted EBITDA margin expansion, while acknowledging that the turnaround “will not be a straight ...